Inhalation anthrax treatment, raxibacumab, gets FDA approval
Anthrax Image/CIA The U.S. Food and Drug Administration today approved GlaxoSmithKline’s raxibacumab injection to treat inhalation anthrax, a lethal form of the infectious disease caused by breathing in the More...